Back to Search
CHRISTINA CELLINI, MD
MD
Surgery Physician
NPI: 1538324561IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
223737(NY)
CMS Specialties
PrimaryCOLORECTAL SURGERY (PROCTOLOGY)
Additional
GENERAL SURGERY
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 2000
Research & Publications (20)
Effect of esophageal ligation on small intestinal development in normal and growth-retarded fetal rabbits.
PMID 16954949·J Pediatr Gastroenterol Nutr·2006
7-preclinical
Effect of epidermal growth factor on small intestinal sodium/glucose cotransporter-1 expression in a rabbit model of intrauterine growth retardation.
PMID 16338313·J Pediatr Surg·2005
7-preclinical
Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery.
PMID 15910716·Am J Surg·2005
8-other
Factors associated with residual breast cancer after re-excision for close or positive margins.
PMID 15383425·Ann Surg Oncol·2004
8-other
Effect of epidermal growth factor infusion on fetal rabbit intrauterine growth retardation and small intestinal development.
PMID 15185220·J Pediatr Surg·2004
7-preclinical
Lupus-associated vasculitis manifesting as acute appendicitis in a 16 year old girl.
PMID 18588697·Pediatr Rheumatol Online J·2008
8-other
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
PMID 17910631·Br J Haematol·2007
3-trial
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
PMID 17485707·J Clin Oncol·2007
4-observational
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
PMID 17114572·Blood·2006
3-trial
Patients with in-stent restenosis have an increased risk of mid-term venous graft failure.
PMID 16928486·Ann Thorac Surg·2006
4-observational
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
PMID 16480429·Eur J Haematol·2006
3-trial
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
PMID 16421414·J Clin Oncol·2006
8-other
Arterial versus venous bypass grafts in patients with in-stent restenosis.
PMID 16159829·Circulation·2005
4-observational
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
PMID 15761019·Blood·2005
4-observational
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
PMID 15693790·Eur J Haematol·2005
3-trial
Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate?
PMID 15615799·Eur Heart J·2005
8-other
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
PMID 15359643·Leuk Lymphoma·2004
3-trial
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
PMID 15257934·Haematologica·2004
3-trial
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
PMID 15245508·Eur J Haematol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE, BOX SURG
ROCHESTER, NY 14642 - Phone
- (585) 273-2727
Quick Facts
- NPI
- 1538324561
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile